367 related articles for article (PubMed ID: 32628792)
1. miR-196a-mediated downregulation of p27
Zhan B; Huang L; Chen Y; Ye W; Li J; Chen J; Yang S; Jiang W
Prostate; 2020 Sep; 80(12):1024-1037. PubMed ID: 32628792
[TBL] [Abstract][Full Text] [Related]
2. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1).
Sun M; Liu XH; Li JH; Yang JS; Zhang EB; Yin DD; Liu ZL; Zhou J; Ding Y; Li SQ; Wang ZX; Cao XF; De W
Mol Cancer Ther; 2012 Apr; 11(4):842-52. PubMed ID: 22343731
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1.
Hou T; Ou J; Zhao X; Huang X; Huang Y; Zhang Y
Br J Cancer; 2014 Mar; 110(5):1260-8. PubMed ID: 24423924
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor-dependent regulation of miR-196a expression controls lung fibroblast apoptosis but not proliferation.
Hecht E; Zago M; Sarill M; Rico de Souza A; Gomez A; Matthews J; Hamid Q; Eidelman DH; Baglole CJ
Toxicol Appl Pharmacol; 2014 Nov; 280(3):511-25. PubMed ID: 25178717
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 stimulates human Tenon's capsule fibroblast proliferation by miR-200b and its targeting of p27/kip1 and RND3.
Tong J; Fu Y; Xu X; Fan S; Sun H; Liang Y; Xu K; Yuan Z; Ge Y
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2747-56. PubMed ID: 24667864
[TBL] [Abstract][Full Text] [Related]
7. Expression of p27((Kip1)), cyclin D3 and Ki67 in BPH, prostate cancer and hormone-treated prostate cancer cells.
Nikoleishvili D; Pertia A; Trsintsadze O; Gogokhia N; Managadze L; Chkhotua A
Int Urol Nephrol; 2008; 40(4):953-9. PubMed ID: 18317945
[TBL] [Abstract][Full Text] [Related]
8. MiR-196a Regulates High Glucose-Induced Mesangial Cell Hypertrophy by Targeting p27kip1.
Wang X; Shen E; Wang Y; Jiang Z; Gui D; Cheng D; Chen T; Wang N
J Lab Autom; 2015 Aug; 20(4):491-9. PubMed ID: 25657172
[TBL] [Abstract][Full Text] [Related]
9. XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1).
Pandhare-Dash J; Mantri CK; Gong Y; Chen Z; Dash C
Prostate; 2012 Jun; 72(8):886-97. PubMed ID: 21932423
[TBL] [Abstract][Full Text] [Related]
10. Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy.
Sun X; Liu Z; Yang Z; Xiao L; Wang F; He Y; Su P; Wang J; Jing B
Diagn Pathol; 2013 Dec; 8():208. PubMed ID: 24350576
[TBL] [Abstract][Full Text] [Related]
11. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
12. microRNA-196a Overexpression Inhibits Apoptosis in Hemin-Induced K562 Cells.
Zhao X; Liu Z; Shen J; Yong L; Xia Y; Bian M
DNA Cell Biol; 2020 Feb; 39(2):235-243. PubMed ID: 31913716
[TBL] [Abstract][Full Text] [Related]
13. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.
Revelos K; Petraki C; Gregorakis A; Scorilas A; Papanastasiou P; Tenta R; Koutsilieris M
In Vivo; 2005; 19(5):911-20. PubMed ID: 16097446
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells.
Ouyang Y; Gao P; Zhu B; Chen X; Lin F; Wang X; Wei J; Zhang H
Mol Med Rep; 2015 Feb; 11(2):1435-41. PubMed ID: 25351256
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract][Full Text] [Related]
17. MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27.
Wang L; Wang Y; Lin J
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8789-8796. PubMed ID: 30575920
[TBL] [Abstract][Full Text] [Related]
18. The differential regulation of microRNAs is associated with oral cancer.
Tsai SC; Huang SF; Chiang JH; Chen YF; Huang CC; Tsai MH; Tsai FJ; Kao MC; Yang JS
Oncol Rep; 2017 Sep; 38(3):1613-1620. PubMed ID: 28713923
[TBL] [Abstract][Full Text] [Related]
19. UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy.
Wan X; Yang S; Huang W; Wu D; Chen H; Wu M; Li J; Li T; Li Y
J Exp Clin Cancer Res; 2016 Feb; 35():34. PubMed ID: 26884069
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL.
Nam RK; Benatar T; Wallis CJD; Kobylecky E; Amemiya Y; Sherman C; Seth A
Prostate; 2019 Sep; 79(12):1422-1438. PubMed ID: 31269290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]